4.6 Review

Applications of liquid chromatography-mass spectrometry based metabolomics in predictive and personalized medicine

Related references

Note: Only part of the references are listed.
Review Biochemical Research Methods

Machine learning meets omics: applications and perspectives

Rufeng Li et al.

Summary: The innovation of biotechnologies has accelerated the accumulation of omics data, leading to the era of 'big data'. Extracting valuable knowledge from omics data remains a challenging issue that requires innovative methods. The development and application of machine learning have greatly enhanced insights into biology and biomedicine, particularly in the field of precision medicine.

BRIEFINGS IN BIOINFORMATICS (2022)

Article Cell Biology

Comprehensive metabolomics expands precision medicine for triple-negative breast cancer

Yi Xiao et al.

Summary: Metabolic reprogramming in triple-negative breast cancer (TNBC) was systematically characterized in this study, resulting in the construction of a large metabolomic atlas. The study classified TNBCs into three distinct metabolomic subgroups and identified subtype-specific metabolites as potential therapeutic targets. The findings suggest the clinical significance of TNBC metabolomics and provide valuable resources for precision treatment of TNBC.

CELL RESEARCH (2022)

Article Biochemistry & Molecular Biology

Metabolomic and microbiome profiling reveals personalized risk factors for coronary artery disease

Yeela Talmor-Barkan et al.

Summary: Multi-omic profiling of patients with coronary artery disease reveals links between alterations in the serum metabolome with genetics, diet, and the microbiome. The study found that these metabolomic alterations are associated with metabolic impairment preceding clinically overt coronary artery disease. The results highlight the importance of understanding risk-factor heterogeneity in coronary artery disease through the serum metabolome.

NATURE MEDICINE (2022)

Editorial Material Gastroenterology & Hepatology

Precision medicine in IBD: genes, drugs, bugs and omics

Ren Mao et al.

Summary: Key studies published in 2021 have made significant progress in the treatment of Crohn's disease, including revealing disease mechanisms, predicting treatment response, and exploring new treatment methods and drugs.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2022)

Article Cell Biology

Lung cancer scRNA-seq and lipidomics reveal aberrant lipid metabolism for early-stage diagnosis

Guangxi Wang et al.

Summary: Lung cancer, the leading cause of cancer-related deaths, can be improved by early detection. A study found dysregulated lipid metabolism in different cell types of early-stage lung cancers. By identifying nine important lipids, a targeted assay was developed with high specificity in detecting early-stage lung cancer. This method demonstrated high sensitivity and specificity in screening and clinical cohorts. Overall, this method shows promise in early lung cancer detection and cancer prevention for high-risk populations.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Gastroenterology & Hepatology

Integrative metabolomic characterisation identifies altered portal vein serum metabolome contributing to human hepatocellular carcinoma

Jinkai Liu et al.

Summary: The study conducted integrative metabolomics analysis on the altered metabolites in HCC patients, revealing distinct clusters of metabolites in serum, liver tissue, and stool samples that differed significantly from healthy controls. Elevated and depleted metabolites identified in portal vein samples may play a role in HCC development. Linoleic acid and phenol were found to inhibit HCC proliferation, suggesting their potential as protective metabolites.
Article Gastroenterology & Hepatology

Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma

Feng Chen et al.

Summary: By integrating untargeted serum metabolomics and metagenome sequencing, this study identified 8 gut microbiome-associated serum metabolites that accurately distinguished CRC and adenoma. The model based on these metabolites showed high diagnostic accuracy for CRC and adenoma, outperforming traditional clinical markers like carcinoembryonic antigen. This suggests that gut microbiome-associated metabolites have potential applications in detecting CRC and adenoma.
Review Biotechnology & Applied Microbiology

Atopic dermatitis: an expanding therapeutic pipeline for a complex disease

Thomas Bieber

Summary: Recent advances in understanding of the complex phenotype and mechanisms underlying atopic dermatitis (AD) have revealed multiple new potential targets for pharmacological intervention. There are now more than 70 new compounds in development, in addition to regulatory approval for several inhibitors in Europe. The potential for a precision medicine approach to enable prevention and more effective long-term control of this complex disease is highlighted.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Biochemistry & Molecular Biology

Delivering precision oncology to patients with cancer

Joaquin Mateo et al.

Summary: Precision medicine is reshaping cancer care, but accessibility to all patients remains a challenge. This Perspective highlights the importance of addressing the challenges in implementing precision oncology, including equal access to genomics tests, robust evidence for new drugs and technologies, interpretation of genomics data by physicians, and empowering patients in shared decision-making.

NATURE MEDICINE (2022)

Editorial Material Oncology

Abundant circulating lipids - a new opportunity for NSCLC detection?

Markus R. Wenk et al.

Summary: This article introduces a diagnostic tool for non-small-cell lung cancer, achieved through mass spectrometry of a targeted panel of lipids. The key aspects for the clinical implementation of this tool and similar tools in other fields of application are also discussed.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Review Multidisciplinary Sciences

Early detection of cancer

David Crosby et al.

Summary: Early detection of cancer is crucial for improving survival rates, but unfortunately, a significant number of cases are diagnosed at an advanced stage. Overcoming various challenges is essential to achieve early detection for all cancers, including understanding high-risk individuals, elucidating the biology and trajectory of precancer and early cancer, and developing sensitive and specific detection technologies.

SCIENCE (2022)

Article Multidisciplinary Sciences

Serum metabolome associated with severity of acute traumatic brain injury

Ilias Thomas et al.

Summary: Acute traumatic brain injury is associated with distinctive serum metabolic patterns, particularly involving compounds related to lipid metabolism, which may indicate protective changes aiming to maintain lipid homeostasis in the brain.

NATURE COMMUNICATIONS (2022)

Article Medicine, General & Internal

Metabolic detection of malignant brain gliomas through plasma lipidomic analysis and support vector machine-based machine learning

Juntuo Zhou et al.

Summary: This study demonstrates the potential of utilizing a machine learning algorithm to analyze lipidomic data for the non-invasive diagnosis of malignant brain gliomas. A panel of 11 plasma lipids was identified as reliable biomarkers, providing a potential method for early detection of MBGs.

EBIOMEDICINE (2022)

Article Chemistry, Analytical

Covid-19 Automated Diagnosis and Risk Assessment through Metabolomics and Machine Learning

Jeany Delafiori et al.

Summary: COVID-19 continues to pose a heavy burden worldwide, emphasizing the importance of patient screening and risk management. Our integration of machine learning algorithms with mass spectrometry led to the development of a rapid platform for distinguishing COVID-19 in plasma samples and providing tools for risk assessment, aiding in patient management and decision-making.

ANALYTICAL CHEMISTRY (2021)

News Item Medicine, General & Internal

COVID-19 Testing Moves Out of the Clinic and Into the Home

Rita Rubin

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)

Review Biochemical Research Methods

Mass spectrometry-based metabolomics diagnostics - myth or reality?

Oxana P. Trifonova et al.

Summary: This report discusses the advantages and challenges of mass spectrometry-based metabolomics in diagnostics and the current trends in implementing metabolomics diagnostics in clinics. Mass spectrometry-based metabolomics has potential as both a preliminary discovery base for routine testing and a multi-test prototype for future clinical practice, with one possible development route being a laboratory-developed test (LDT).

EXPERT REVIEW OF PROTEOMICS (2021)

Editorial Material Biochemical Research Methods

Single-cell metabolomics hits its stride

Caroline Seydel

NATURE METHODS (2021)

Article Oncology

Identification of diagnostic markers and lipid dysregulation in oesophageal squamous cell carcinoma through lipidomic analysis and machine learning

Yuyao Yuan et al.

Summary: By integrating lipidomics and machine-learning algorithms, we developed an optimized diagnostic model with a panel of 12 lipid biomarkers for detecting ESCC. Integrative analysis revealed potential mechanisms of lipid dysregulation in the serum.

BRITISH JOURNAL OF CANCER (2021)

Article Gastroenterology & Hepatology

Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis

Jasmohan S. Bajaj et al.

Summary: By analyzing serum and urine metabolomics, this study effectively predicts the development of AKI and the need for dialysis in patients with cirrhosis, which is crucial for initiating renal protective measures early.

HEPATOLOGY (2021)

Article Multidisciplinary Sciences

Metabolic detection and systems analyses of pancreatic ductal adenocarcinoma through machine learning, lipidomics, and multi-omics

Guangxi Wang et al.

Summary: The study introduced a minimally invasive approach using machine learning and lipidomics to detect PDAC, achieving high accuracy rates through feature optimization and mass spectrum analysis. Single-cell sequencing, proteomics, and mass spectrometry imaging were applied to reveal lipid alterations in PDAC tissues, suggesting the potential for early detection of PDAC.

SCIENCE ADVANCES (2021)

Review Biochemical Research Methods

Advanced tandem mass spectrometry in metabolomics and lipidomics-methods and applications

Sven Heiles

Summary: Metabolomics and lipidomics are driving forces in the omics era, with tandem mass spectrometry methods playing a crucial role in characterizing the structural details of metabolites and lipids. Recent advancements in alternative tandem MS methodologies aim to provide full structural characterization of these compounds. The review critically examines the principles, capabilities, drawbacks, and initial applications of these advanced tandem mass spectrometry strategies in the fields of metabolomics and lipidomics.

ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2021)

Review Biotechnology & Applied Microbiology

Using machine learning approaches for multi-omics data analysis: A review

Parminder S. Reel et al.

Summary: With the advancement of high-throughput omics technologies, it is crucial for biomedical research to adopt integrative approaches to analyze diverse omics data using machine learning algorithms. This can lead to the discovery of novel biomarkers and improve disease prediction and precision medicine delivery.-Methods in machine learning have enabled researchers to gain a deeper insight into biological systems and provide recommendations for interdisciplinary professionals looking to incorporate machine learning skills in multi-omics studies.

BIOTECHNOLOGY ADVANCES (2021)

Review Oncology

Tumor organoids: Opportunities and challenges to guide precision medicine

Vivien Veninga et al.

Summary: Tumor organoids, proposed as a model system for precision medicine, have the unique ability to retain characteristics of the original tumor, making them valuable for individual patient cancer research. Although the in vitro responses of tumor organoids to drugs are correlated with patient responses, substantial challenges remain and large cohort prospective studies are needed before implementation in clinical cancer care can be considered. Due to their personalized characteristics and direct link with patient data, tumor organoids also have great potential in preclinical research.

CANCER CELL (2021)

Editorial Material Gastroenterology & Hepatology

Metabolomics to Predict Acute Kidney Injury in Cirrhosis

Salvatore Piano et al.

HEPATOLOGY (2021)

Review Cardiac & Cardiovascular Systems

Towards precision medicine in heart failure

Chad S. Weldy et al.

Summary: This review summarizes the biology of heart failure, highlighting the importance of genetic predisposition in individual patient for precision therapy. It discusses the causal relationships between genetic contributors and traditional structure-based remodelling outcomes, as well as the mechanisms of action of both traditional and novel therapeutics.

NATURE REVIEWS CARDIOLOGY (2021)

Review Gastroenterology & Hepatology

Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests

Mojgan Masoodi et al.

Summary: Metabolomics and lipidomics approaches are utilized to identify biomarkers for NAFLD, with significant contributions in clinical studies; key metabolic pathway alterations in NAFLD and NASH have been identified, potentially serving as biomarkers for non-invasive diagnostic tests. Despite the discovery of potential biomarkers, few have been validated for clinical use.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2021)

Article Multidisciplinary Sciences

The trans-omics landscape of COVID-19

Peng Wu et al.

Summary: The authors conducted blood sampling and multi-omics analysis on COVID-19 patients of various disease severities, reporting a trans-omics landscape of COVID-19. The study found differences in characteristics between patients with different disease severities, suggesting potential clues for pathophysiology and therapeutic strategies of COVID-19.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity

Miriam Sindelar et al.

Summary: Through untargeted metabolomics analysis of plasma from COVID-19 patients, a predictive model of disease severity was established based on metabolic profiles, including metabolites directly related to disease progression that return to baseline levels upon recovery. These metabolites were also validated to be altered in a hamster model of COVID-19.

CELL REPORTS MEDICINE (2021)

Editorial Material Cardiac & Cardiovascular Systems

Predicting longevity using metabolomics: a novel tool for precision lifestyle medicine?

Jean-Pierre Despres

NATURE REVIEWS CARDIOLOGY (2020)

Article Chemistry, Analytical

Deep Learning for the Precise Peak Detection in High-Resolution LC-MS Data

Arsenty D. Melnikov et al.

ANALYTICAL CHEMISTRY (2020)

Article Multidisciplinary Sciences

Precision medicine integrating whole-genome sequencing, comprehensive metabolomics, and advanced imaging

Ying-Chen Claire Hou et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Integration of molecular profiles in a longitudinal wellness profiling cohort

Abdellah Tebani et al.

NATURE COMMUNICATIONS (2020)

Article Biochemistry & Molecular Biology

Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19

Yapeng Su et al.

Review Spectroscopy

Metabolomics toward personalized medicine

Minnie Jacob et al.

MASS SPECTROMETRY REVIEWS (2019)